This is, according to ZF data, the first pharmaceutical manufacturing facility in Romania to reach a turnover of EUR100 million. According to a ranking put together by ZF in 2010, GSK’s Brasov plant was no. 1 among the largest local drug manufacturers in terms of turnover, with EUR90.4 million, followed by Terapia Ranbaxy (EUR89.4 million) and Sandoz (EUR69 million).
“Around 50% of the volume of production at our Brasov plant is exported to 80 countries. Last year exports were slightly below our established ceiling, but we hope to grow in 2012,” says Pascal Prigent, general manager of GSK Romania, who came to the helm of local operations of the UK group just over a year ago. Prigent explains, though, that the evolution of exports depends on the international economic situation.
At the Brasov plant GSK makes drugs used to treat HIV, antidepressants and generics.
GSK took over Europharm plant in the early 2000s from Romanian businessman Mihai Miron. GSK also took over Europharm Distributie wholesaler, with turnover of EUR250 million last year.
(English version by Daniela Stoican)